November 1, 2022
  • Johnson & Johnson (J&J) agreed to buy heart pump maker Abiomed Inc. for $16.6 billion in an all-cash deal, building out its cardiovascular portfolio. The deal comes as J&J is spinning off its consumer health business to focus on its pharmaceuticals and medical devices operations and pursing a more aggressive M&A stance under new CEO Joaquin Duato. (Press release here; Articles here, here, and here)